Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. (cancernetwork.com)
[17] An in vivo mouse leptomeningeal model demonstrated that osimertinib slowed the development of leptomeningeal carcinomatosis in both the treatment - naive and prior EGFR TKI — refractory settings. (cancernetwork.com)
But here his scan showed that his liver mets were decreased, the peritoneal carcinomatosis was disappearing... it was just amazing. (cancerresearch.org)